The Werner syndrome RECQ helicase as a therapeutic target: new insights.

Julia M Sidorova, Raymond J Monnat

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. · pubmed

Paper

Abstract

The

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that targeting the Werner syndrome RECQ helicase could provide new therapeutic strategies for age-related diseases. The research addresses a potential root cause of aging by exploring the role of a specific helicase in cellular aging processes.

Author of this paper? Send a correction.